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Glomerular C3 receptors in human renal disease. The relation-
ship between glomerular C3 receptor activity and intraglomerular
C3 deposition was studied in 73 cases of various forms of renal
disease. C3 receptor activity was measured by enumeration of
complement-coated sheep red blood cells (1gM EAC) that adhered
to glomeruli in frozen sections and expressed as a percentage of
the mean number present in control kidneys. Adjacent sections
were studied for the presence and distribution of C3 deposits. The
precise location of corresponding dense deposits was determined
through l- sections or electron micrographs. Marked depression
of C3 receptor activity was found in most cases in which there was
accumulation of C3 along the glomerular basement membrane,
irrespective of whether the deposits were in a subepithelial, intra-
membranous, or subendotheial location. In contrast, when C3
was not detectable or was found exclusively in the mesangium, C3
receptor activity was affected only moderately, if at all. These data
are consistent with the hypothesis that the interaction of C3 with
podocytes is a major determinant in the loss of C3 receptor activity
in glomerular disease, but do not exclude the possibility that
interaction with mesangial or endothelial cells may also influence
C3 receptor activity.
Récepteurs glomérulaires de C3 dans les affections rénales. La
relation entre l'activitC du récepteur glomérulaire de C3 et le dépôt
intraglomérulaire de C3 a etC étudiCe dans 73 cas de maladies
rénales diverses. L'activitC rCceptrice de C3 a Cté mesurée par la
numeration des globules rouges de chèvre recouverts de complC-
ment (1gM EAC) qui adherent au glomCrule sur des coupes conge-
lees. Ce nombre est exprimé en pourcentage du nombre moyen de
tels globules rouges fixes par les reins contrôles. Les coupes
voisines ont CtC étudiées pour reconnaitre la presence et évaluer Ia
distribution des depots de C3. La localisation precise des dCpôts
denses correspondants a ete dCterminée au moyen de coupes de
l- ou de la microscopie électronique. Une diminution importante
de l'activité réceptrice de C3 a été trouvée dans la plupart des cas
dans lesquels il y a une accumulation de C3 le long de la membrane
basale du glomérule que les dépôts soient sous-epitheliaux, intra-
membraneux ou sous-endothéliaux. Au contraire, quand le C3
n'est pas detectable ou bien seulement mCsangial, I'activité rCcep-
trice de C3 n'est que faiblement. ou pas du tout, modffiée. Ces
résultats sont en accord avec l'hypothèse selon laquelle i'm-
teraction de C3 avec les podocytes est un determinant majeur
de la perte d'activité réceptrice de C3 dans les affections gloméru-
laires, mais ils ne permettent pas d'exclure que l'interaction avec
les cellules mésangiales ou endothCliales puisse aussi influencer
l'activité réceptrice.
In 1975, Gelfand, Frank, and Green reported that
normal human glomeruli possess receptors for the
activated third component of complement (C3b), as
revealed by the adherence of sheep erythrocytes
coated with antibody and complement (EAC) to gb-
meruli in frozen sections [1]. More recently, it was
reported that in certain diseases characterized by C3
deposition in gbomeruli, receptor activity is dimin-
ished or absent [2-4]. The relationship between the
site of intraglomerular C3 deposition and loss of
receptor activity, however, remains uncertain. So-
bel, Gabay, and Lagrue reported that mesangial but
not subepithelial C3 deposition was associated with
loss of receptor activity [3]. In contrast, Nagle et a!
reported that C3 receptor activity was preserved in
diseases with mesangial C3 deposits but was lost in
association with subepithelial deposits [51.
In view of these discordant results and because of
the potential importance of glomerular C3 receptors
in human renal disease, we performed further studies
of the C3 receptors in a variety of well characterized
renal diseases, with particular emphasis on the corre-
lation between C3 receptor activity and the site and
extent of intraglomerular C3 deposition.
Methods
Seventy-three biopsy specimens were obtained for
study from the files of the Massachusetts General
Hospital (1971—1976) and the Children's Hospital
Medical Center (1973— 1976), Boston, Massachu-
setts. We selected for study several groups of gb-
merular diseases with different, characteristic pat-
terns of C3 accumulation, as seen by
immunofluorescence. All examples of each disease
type in which sufficient material was available for
study were included. Normal renal tissue was ob-
tained from nephrectomy or autopsy specimens.
Preparation of tissue. Biopsy specimens were di-
vided into three portions for histologic, electron-
microscopic and immunofluorescent studies. For his-
tologic preparations, a portion of the specimen was
fixed in a Helley type of fixative (FU-48, Technicon
Corp., Tarrytown, N.Y.) or formalin, and 2- sec-
tions were prepared from paraffin-embedded mate-
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na!. The sections were stained with hematoxylin and
eosin, periodic acid-Schiff reagent, and in many
cases by the periodic acid-methenamine silver and
azocarmine methods.
For electronmicroscopic studies or l-t sections, a
second portion was fixed for 5 hr at room tempera-
ture in 2.5% glutaraldehyde-2% paraformaldehyde in
0.1 M cacodylate buffer (pH, 7.4) containing 0.33 mg
per ml of calcium chloride 16]. Tissue was washed in
cold 0.1 M cacodylate buffer, postfixed for 1 hr in 2%
osmium tetroxide, dehydrated in a series of alcohols,
and embedded in Epon. One-micron sections were
stained with Giemsa reagent, diluted 1:10 in 2% so-
dium borate [71. For electronmicroscopy, thin sec-
tions were stained with uranyl nitrate and lead
citrate.
The third part of the specimen was embedded
fresh in either OCT compound (Ames Tissue Tek) or
gelatin and rapidly frozen in a cryostat or in dry ice!
acetone and stored at —70°C until used. At the time
of biopsy all cases were studied by immunofluores-
cence for the presence of C3, IgG, IgA, 1gM, IgD,
IgE, fibrinogen, and albumin.
For the present study, frozen blocks were recut to
measure C3 receptor activity (see below); adjacent
sections were stained for C3 deposits. Sections were
air-dried, washed in phosphate-buffered saline (PBS)
(pH, 7.3) and incubated for 30 mm with fluorescein-
conjugated goat antihuman C3 (Cappel Laboratories,
Downington, Pa.). After washing in PBS, the sec-
tions were mounted in Elvanol (Elvanol 5 1-05 E. I.
du Pont de Nemours, Co.) and examined with a
Zeiss microscope which was equipped with an HBO
200 high pressure lamp and FITC/50 filter combina-
tion. The location of the C3 deposits was determined
by two or more observers who had no knowledge of
the diagnosis or the C3 receptor activity. The pat-
terns of C3-staining recorded for this study were: 1)
exclusively mesangial, 2) exclusively along the gb-
merular basement membrane (GBM) (as granular,
broad irregular or linear patterns), or 3) combina-
tions of mesangial and GBM staining. The intensity
of the fluorescence was recorded on an arbitrary
scale of 0 to 4+.
Preparation of sheep erythrocyte reagents. Sheep
erythrocytes were collected in Alsever' s solution
and washed in 0.15 M sodium chloride. A 5% suspen-
sion of washed sheep erytbrocytes (E) in 0.15 M
sodium chloride was incubated with subagglutinating
amounts of rabbit IgG or 1gM antibodies against
sheep erythrocytes (Cordis Laboratory, Miami, Fla.)
for 30 mm at 37°C to form IgG EA and 1gM EA
reagents, respectively. After three washes in 0.15 M
sodium chloride, a 5% suspension was prepared in
veronal-buffered saline (VBS) (pH, 7.3; with 0.5 mivi
magnesium chloride, 0.15 m calcium chloride, and
0.1% gelatin). To obtain 1gM EAC, the 1gM EA
suspensions were incubated with equal volumes of
fresh CD mouse serum at a 1:5 dilution in VBS at
37°C for 30 mm. Cells were washed three times in
VBS, stored on ice, and used the same day.
Detection of glomerular C3 receptors. Initial stud-
ies showed no difference in the number of 1gM EAC
bound to glomeruli in 2-/L as compared with 4-j
frozen sections; slightly more were bound to 6-j
sections. Therefore, 2- to 4- sections were used.
Sections were washed in PBS, layered with a 1%
solution of the sheep red cell reagents (1gM EAC,
IgG EA, E), and incubated in a moist chamber at
room temperature for 30 mm. To remove nonadher-
ent red cells, each slide was repeatedly agitated in
PBS, then fixed with 3% glutaraldehyde in PBS and
stained with hematoxylin and eosin. The numbers of
adherent 1gM EAC over glomeruli were counted.
One control section (obtained from the nondiseased
part of a nephrectomy specimen with renal cell carci-
noma) was studied with each assay. The glomeruli in
this case appeared normal and showed no staining
for C3. C3 receptor activity was measured by count-
ing the mean number of adherent erythrocytes (1gM
EAC) per glomerulus in each case and was
expressed as a percentage of the mean number of
adherent red cells per glomerulus as compared with
the value obtained in the normal control studied the
same day. Only specimens with three or more suita-
ble glomeruli were included; an average of eight
glomeruli were counted. Fragmented or globally
sclerotic glomeruli were excluded. No obvious effect
of storage upon glomerular C3 receptor activity
could be detected; counts on specimens that had
been stored for as long as five years (including some
with normal counts) did not appear to differ from
those on similar current speciments.
Results
Glomerular C3 receptor activity: Normal kidneys.
Four specimens obtained from normal renal tissue
were studied, including three obtained at autopsy
and one at nephrectomy for renal cell carcinoma. In
frozen sections, few if any endogenous erythrocytes
remained because of lysis during freezing. Following
layering of E or 1gM EA reagents over sections of
normal kidney, no adherent red cells were seen; after
layering with 1gM EAC, erythrocytes were found
over gbomeruli, but not other normal structures, al-
though they were sometimes seen over interstitial
mononuclear infiltrates.
The mean number of 1gM EAC adhering to normal
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glomeruli in assays performed on different days was
229 80 (sEM) (range, 128 to 355). Some of the
adherent red cells were present on the urinary side of
the capillary loops, presumably in association with
podocytes (Fig. 1). It could not be determined
whether there was sticking to endothelial or mesangi-
al cells. For the most part, erythrocytes were not
associated with parietal epithelial cells, although in
an occasional glomerulus a few adherent red cells
were seen in this location.
Glomerular C3 receptor activity: Diseased kid-
neys. The data that relate the presence and location
of glomerular C3 deposition to complement receptor
activity are given in Figure 2. The correlation be-
tween disease categories, C3 pattern, and C3 recep-
tor activity is given in Table 1.
Glomeruli with no C3 deposition or with C3 exclu-
sively in the mesangium had C3 receptor activity that
ranged from normal (100%) to moderately reduced
(50%); the mean C3 receptor activity was 68 and
80%, respectively (Fig. 3). These mean values do not
differ significantly from those of control specimens.
In contrast, glomeruli with extensive C3 deposits
along the GBM usually had absent or markedly re-
duced C3 receptor activity; the mean value for this
group was 20%: this value is significantly different
from controls (P < 0.001). In particular, in seven of
nine cases of idiopathic membranous glomerulo-
nephritis (Fig. 3), C3 receptor activity was very low
(mean activity, 11%), and all of seven cases of severe
lupus nephritis had undetectable or very low recep-
tor activity (mean activity, 7%). Overall, however,
the C3 receptor activities of the group with exclu-
sively GBM C3 deposition (20%) did not differ signif-
icantly from those with combined mesangial and
GBM C3 deposition (34%) (P > 0.1).
Further observations were made to determine
whether depression of C3 receptor activity could be
related to the site of abnormal deposits along the
GBM, as seen in one-micron sections or electronmi-
crographs (Fig. 4). In general, dense deposits ap-
peared to correspond to sites of C3-staining seen by
immunofluorescence. There were exceptions, how-
ever. Two cases of acute glomerulonephritis had
only mesangial C3-staining, and yet subepithelial de-
posits ("humps") were present (rare in one case and
numerous in the other). In each, faint granular stain-
ing for IgG was found along the GBM. The mean C3
receptor activity in these two cases was 85%. In two
of five cases of dense deposit disease, electronmi-
croscopy showed widespread typical intramembran-
ous deposits in the GBM, yet C3 was detectable only
in mesangial regions (as characteristic "globules") or
as faint, irregular staining along the GBM. In these
two cases, C3 receptor activity was 80% and 100%,
respectively. If all cases in which immunofluores-
cence failed to show C3-staining in sites with dense
deposits are excluded, 11 of 16 cases with extensive
dense deposits present only along the GBM had
markedly reduced or absent C3 receptor activity (4
of membranous glomerulonephritis, 2 of acute gb-
merulonephritis, 3 of dense deposit disease, and 2 of
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Fig. 1. Frozen Section showing normal glome ru/us with adherent
1gM EAC sheep red blood cells (hematoxylin and eosin stain,
magnffication x 250).
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Fig. 2. Relationship between the location of C3 deposits and
glomerular C3 receptor activity. Abbreviations used are MES,
mesangium; GBM, glomerular basement membrane.
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Table 1. C3 receptor activity and location of C3 deposits by diagnostic categories
Diagnosis
Total
no.
studied
Location of C3 deposits by
ilnmunofluorescencea
Mean C3 receptor
activity (± saM)None
Mesangial
Mesangial and GBM GBM
Nonglomerular renal diseaseb
Minimal change disease (lipoid nephrosis)
Focal glomerular sclerosis (with the nephrotic syndrome)
Berger's disease (IgA/IgG nephropathy)
Anaphylactoid purpura
Acute glomerulonephritis
Membranoproliferative glomerulonephritis (MPGN type
I, with subendotheial deposits)
Dense deposit disease (MPGN type Ii)
Idiopathic membranous glomerulonephritis
Lupus nephritis (severe)
Anti-GBM disease (Goodpasture's syndrome)
Idiopathic crescentic (rapidly progressive)
glomerulonephritis
Unclassified immune complex glomerulonephritis
Endstage renal diseased
3
5
5
8
6
9
4
5
9
7
1
1
5
5
75% (1)
75% (3)
43% (1)
100% (2)
100% (2)
85% (2) 48% (2)
70 %(5) 16% (3)
50% (1) 55% (5)
85% (2) 42% (4)
55% (4)
80% (1) 33% (3Y
34% (3)
9% (6)
30% (1)
15% (3)
51% (1)
45% (2)
5% (1)
11% (7)
0% (1)
14% (1)
14% (2)
90 10
86 10
63 10
49 11
54 1151 9
55 6
37 21
16 77 3
14
30
14 76 2
Mean C3 receptor activity 68 11 81 7 34 5 20 8
a C3 receptor activity (%) and number of cases in parentheses.
One case of acute interstitial nephritis, and two cases of acute tubular necrosis. Each had normal glomerular histology, two had ito 2+
mesangial C3-staining without immunoglobulin deposits.
Individual values were 100%, 0%, and 0%. The one with 100% C3 receptor activity had only trace C3-staining along the GBM; and the
two others had 4+ C3-staining along the GBM.
U Five cases of endstage glomerular disease had scanty and irregular C3 deposits, and their location could not be determined.
unclassified immune complex glomerulonephritis).
The five exceptional cases were membranous gb-
merulonephritis (2 cases), membranoproliferative
gbomerulonephritis (1 case), and acute glomerulo-
nephritis (2 cases). Further analysis failed to disclose
a clear relationship between the site of the deposits
along the GBM and loss of receptor activity. Thus,
although most cases with only subepithelial deposits
typically showed profound diminution or absence of
receptor activity, a few did not. Furthermore, in two
of three cases with exclusively subendothelial depos-
its, marked reduction of receptor activity was found.
In all cases of lupus nephritis studied, there were
subendothelial, subepithelial and intramembranous
deposits, and in all these specimens the receptor
activity was barely detectable.
One case of anti-GBM disease with characteristic
linear accumulation of IgG and C3 along the GBM
(without electron dense deposits) was studied and
was found to have markedly depressed activity
(14%). Although most of the gbomeruli in this speci-
men were severely damaged, they were not
sclerosed.
In five cases, well developed cellular crescents
were present. 1gM EAC adhered to crescents in only
one case, and in this instance only a few scattered
clusters of erythrocytes were present. Several cases
with normal or only mildly reduced C3 receptor
activity had marked mesangial hypercellularity.
Even in these specimens, where there was consider-
able expansion of mesangial regions, it was not cer-
tain that erythrocytes were binding to mesangial
cells. Sclerotic glomeruli always failed to show C3
receptor activity. The presence of increased num-
bers of neutrophils in glomeruli, as were seen in two
cases of acute glomerulonephritis, did not appear to
increase 1gM EAC-binding (20 and 15% of C3 recep-
tor activity, compared with a mean of 51 9% for
the group of acute gbomerubonephritis).
With the use of reagents E or IgG EA (to detect Fe
receptors), no adherent red cells were found over
normal or abnormal glomeruli, including those with
cellular crescents. IgG EA red cells occasionally
were found focally over interstitial areas, especially
in association with cellular infiltrates.
Attempts to restore glomerular C3 receptor activi-
ty. In several cases with reduced gbomerular C3
receptor activity, attempts were made to restore
activity by elution of complement from the gbomer-
uli, as described by Sobel et al [3]. Frozen sections
were incubated in 0.02 M sodium citrate (pH, 3.2) or
O.02M glycine (pH, 2.4) for two hours; this treatment
did not reduce the C3 receptor activity in normal
controls. Incubated and untreated sections were
assayed for glomerular C3 deposits by immunofluo-
rescence and C3 receptor activity. The following
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diseases were studied in this fashion: membranous
glomerulonephritis (4 cases), Berger' s nephropathy
(3 cases), lupus nephritis (2 cases), dense deposit
disease (1 case), anaphylactoid purpura (1 case), and
membranoproliferative glomerulonephritis (1 case).
In all instances, staining for C3 was lost after acid
treatment. There was, however, no appreciable
increase in C3 receptor activity (mean change, —3
18%; not significant by paired t test).
Discussion
In the present study, we found that in a variety of
glomerular diseases characterized by deposits of C3
there was often a marked decrease or a complete loss
of glomerular C3 receptor activity. The degree and
frequency of reduction of C3 receptor activity was
Fig. 3, A and B. A case of Berger's disease (IgAIIgG) nephropathy. In panel A, the C3 deposition in this glomerulus as shown by
immunofluorescence is exclusively in the mesangium; in panel B, the same glomerulus in an adjacent section has adherent 1gM EAC (the
mean C3 receptor activity was 50%). C and D. A case of membranous glomeralonephritis. In panel C C3 deposits in this glomerulus as seen
by immunofluorescence are exclusively along the GBM; in panel D, the glomerulus in an adjacent section had almost no adherent 1gM EAC
(the mean C3 receptor activity was 3%).
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found no reduction in any of 11 cases of membranous
A A glomerulonephritis; however, they found, as we did,
moderate diminution in some cases with mesangial
C3 accumulation. It is unlikely that differences in
A diagnostic criteria are responsible for these discrep-
ancies. It is possible that technical factors are in-
• volved. In particular, our methods differed from
those of Sobel et al, and we found five to ten times
more adherent erythrocytes (1gM EAC) over normal
• glomeruli than they did. The findings of Nagle et al
were based in part on the use of complement-coated
bacteria [5]. Since we found variations in the C3
receptor activity in association with each pattern of
C3 deposition, it may be that the different results
reflect the relatively small number of cases studied,
or the way in which they were selected. Thus, Sobel
et al [3] studied only patients who had normal serum
creatinine levels, whereas ours were not selected on
the basis of renal function.
The mechanisms responsible for the loss of C3
receptor activity seen in many specimens with gb-
merular C3 deposition is unknown. One possibility is
that the deposited C3 occupies the receptors, so that
they are not available to react with the 1gM EAC
reagent in vitro. If this were so, it might be possible
to restore receptor activity by removal of bound C3
through acid treatment (thereby disrupting antigen
antibody complexes). However, although Sobel et al
have reported success with this maneuver [3], we
were unable to confirm their results. Furthermore, if
deposits located exclusively along the epithelial side
of the GBM are able to block receptors, it would be
necessary to assume that the receptors present on
the outer surface of the cells (as has been seen by
scanning electronmicroscopy [8, 9]) are somehow
translated to the basement membrane side of the cell
as the result of interaction with C3 at that site (a sort
of capping phenomenon). Our data are consistent
with another explanation, namely that the receptors
are actually lost from the cell surface after interac-
tion with C3, possibly through phagocytosis or endo-
cytosis as described for other cells [10—131. It is also
possible that C3b in the urinary space could bind to
the C3 receptors in amounts not detectable by immu-
nofluorescence, which might explain some of the
lack of correlation between the site of C3 accumula-
tion as detected by immunofluorescence and recep-
tor activity.
Although our results show that there is a direct
relationship between C3 deposition and loss of
receptor activity, it is also clear that severe gbomeru-
lar damage can be associated with lack of receptor
activity, even in the absence of C3 deposits. For this
reason, in specimens with C3 and extensive glomeru-
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Fig. 4. Relationship between the location of dense deposits, as
seen in 1-micron sections or electron micro graphs, and glomerular
C3 receptor activity. Cases with deposits in multiple locations are
excluded from this table. Closed circles denote cases with staining
for C3 by immunofluorescence corresponding to the location of
dense deposits (those without dense deposits lacked C3 deposi-
tion). Triangles denote cases without C3-staining corresponding to
the location of dense deposits. Open circles denote cases with only
scanty dense deposits and corresponding C3-staining. Abbrevia-
tions used are MES, mesangium; SEND, subendothelial; SEPT,
subepithelial; TM, intramembranous.
considerably influenced by the site of deposition of
C3, as determined by immunofluorescence. In dis-
eases with mesangial deposits (even when intense
and widespread), C3 receptor activity was usually
normal or only moderately reduced, whereas when
deposits were present along the GBM, activity was
markedly diminished or absent in most cases. There
appeared to be no clear relation, however, between
the site of dense deposits (presumed to include C3)
along the GBM and the loss of receptor activity,
since reduced levels were found in association with
subepithelial, intramembranous, or subendothelial
deposits, as seen in electronmicrograph or one-mi-
cron sections. Furthermore, when electron dense
deposits (subepithelial or intramembranous) were
present without corresponding staining for C3 by
immunofluorescence, C3 receptor activity was gen-
erally preserved.
Our results are somewhat different from those
obtained in previous studies. Nagle et al 15] reported
that C3 receptor activity was decreased only (and in
all cases studied) in association with subepithelial
deposits containing C3, but was not affected by intra-
membranous C3 accumulation (in anti-GBM dis-
ease), subendothelial, or mesangial deposits. Our
findings also differ from those of Sobel et al [3], who
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Jar damage (especially with some degree of scleros-
is), it is not always clear whether loss of receptor
activity should be attributed to the deposits of C3.
In view of our Jack of understanding of the funda-
mental mechanisms accounting for loss of glomerular
C3 receptor activity, it is not surprising that although
lost in most instances, normal activity was preserved
in some cases with extensive C3 accumulation and
subepithelial deposits. In some instances, especially
in acute glomerulonephritis, this may have been due
to the scarcity of the deposits, but in others, espe-
cially cases of membranous glomerulonephritis, this
explanation would not appear to suffice. It may also
be that in some of these cases the deposits were not
actually in contact with the epithelial cells, owing to
the formation of a new layer of basement membrane
material on their outer side, as is known to occur in
membranous glomerulonephritis [14]. In one of our
two cases of membranous glomerulonephritis with
only slight depression of receptor activity, however,
electronmicroscopy showed deposits apparently in
direct contact with epithelial cells (Stage II) [14].
Scanning electronmicroscopy has shown that C3
receptors are present on podocytes [8, 9] although
this approach would not readily detect receptors on
mesangial or endothelial cells. Other indirect evi-
dence for the presence of receptors on podocytes is
provided by our observations, as well as those of
others [4, 91, showing that receptor activity is fre-
quently lost in association with subepithelial depos-
its. The finding that activity is depressed in some
cases with mesangial or subendothelial deposits sug-
gests that receptors may be present also on endothe-
hal or mesangial cells. It is of interest that cells
believed to be of mesangial origin obtained from
isolated rat glomeruli manifest C3 and Fc receptors
following cultivation in vitro [15]. Receptors are not
detectable in frozen sections of kidneys of normal
rats (or other experimental animals), but this may be
due to technical factors.
In the present study, neither Fc nor C3 receptors
were convincingly demonstrated in cellular cres-
cents. These findings (especially the lack of Fc
receptors) argue against, but do not exclude, the
possibility that majority of cells in crescents are
derived from circulating monocytes, as has been
recently suggested [16, 17].
The possible role of the C3 receptor in glomerular
disease is uncertain. Gelfand et at suggested that the
C3 receptors may provide a mechanism for the arrest
of circulating C3b containing complexes [2]. How-
ever, if the receptors are, in fact, confined to podo-
cytes, it is difficult to imagine how they could trap
complexes present in the circulation. Moreover,
even if present on endothelial and mesangial cells,
the receptors might not be of critical importance in
glomerular localization. Studies by Haakenstad and
Mannik in the mouse indicate that the ability of
complexes to fix complement does not appreciably
increase their clearance by the RES [18], nor favor
their arrest in glomeruli following i.v. infusion [19].
It is possible, however, that C3 receptors are impor-
tant in the phagocytosis and removal of complexes
once deposited.
In any case, the observation that C3 receptor
activity is often altered in association with C3 depo-
sition suggests that the receptors do play a role in
certain kinds of glomerular disease. The absence of
detectable C3 receptors in tissue sections in experi-
mental animals has impeded progress in this area. It
seems likely that interaction of the receptors on gb-
merular cells with C3b may have important effects
on these cells, in ways that remain to be determined.
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